Arthrosi Therapeutics

Series-B
Biotech & Healthcare San Diego, United States Founded 2018 11–50 employees
Total Funding $228M
Latest Round $153M Series-B
Last Announced Oct 8, 2025
Investors 10 Backers
Decision Makers 6 Available

About Arthrosi Therapeutics

Arthrosi Therapeutics develops pharmaceutical treatments through clinical research and drug development programs.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B
Global Headquarters San Diego, United States
Year Founded 2018
Team Size 11–50 employees
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website Not publicly listed
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $153,000,000 · Series-B

    Backed by Prime Eight Capital

  2. Capital Raise

    Raised $75,000,000 · Series-B

    Backed by Guangrun Health Industry

  3. Milestone

    Company founded

    San Diego, United States

Investors & Backers

10
Guangrun Health Industry
Lead
Prime Eight Capital
Lead
CR Biotech
Highlight Capital
HM Venture Partners
Maxpro Ventures
Reichstein Biotech
ReliantTech
Viva BioInnovator
Viva Ventures Biotech Fund

Funding History

2 Rounds
Series-B equity · Oct 8, 2025

Round backers: Prime Eight Capital

Series-B equity · Jul 12, 2023

Round backers: Guangrun Health Industry

$75,000,000 finsmes.com

Founders & Leadership

5

Litain Yeh

Founder

Work email & phone locked Unlock →

Philip Moody

CFO

Work email & phone locked Unlock →

Robert Thomas Keenan

Chief Medical Officer

Work email & phone locked Unlock →

Shunqi Yan

Founder

Work email & phone locked Unlock →

Stephen Smolinski

Chief Business Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts